Tag: disease modifying therapies

New publication from MSIF on ethical use of off-label DMTs receives global endorsement

A new study examined different disease modifying therapies and their ability to slow the onset of secondary progressive MS.

New research, involving 874 people who had used disease-modifying therapies during the previous 5 years, has shown a link between more effective disease-modifying therapies and an increased level of employment, work attendance and productivity at work.